DIA/AAPS Co-Sponsored Conference To Examine The Immunogenicity Of Therapeutic Proteins

Main Category: Pharma Industry / Biotech Industry
Also Included In: Pharmacy / Pharmacist;  Conferences;  Immune System / Vaccines
Article Date: 31 Jul 2008 - 5:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


The Drug Information Association (DIA) and the American Association of Pharmaceutical Scientists (AAPS) will co-sponsor Immunogenicity of Therapeutic Proteins (September 10 -12; Bethesda, MD).

Discussion topics will include:

- Current practices in immunogenicity evaluation
- Role of preclinical assessment
- Challenges of clinical immunogenicity assessment: case studies
- Risk assessment and risk management
- Regulatory perspectives
- Future of immunogenicity assessment

"Industry practices in immunogenicity assessment are becoming more unified though challenges still exist in terms of technology and reduction to practice," says Program Chair Steven J. Swanson, PhD, Executive Director, Medical Sciences, Clinical Immunology Department, Amgen, Inc. "This conference will review key aspects of assay development and validation as well as discuss challenges in implementation of these assays, data interpretation, and relevance to clinical outcomes."

About the Drug Information Association (DIA)

DIA serves more than 30,000 professionals in the biotechnology, pharmaceutical and regulatory industries worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, and Mumbai, India, the Association is led by its volunteer-based Board of Directors and executive management team.

Drug Information Association

About the American Association of Pharmaceutical Scientists (AAPS)

AAPS is a professional, scientific society of more than 13,500 members employed in industry, academia, government and other research institutes worldwide. Founded in 1986, AAPS provides a dynamic international forum for the exchange of knowledge among scientists to enhance their contributions to public health. AAPS offers timely scientific programs, on-going education, information resources, opportunities for networking, and professional development.

American Association of Pharmaceutical Scientists

Article adapted by Medical News Today from original press release.
Visit our pharma industry / biotech industry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Drug Information Association. "DIA/AAPS Co-Sponsored Conference To Examine The Immunogenicity Of Therapeutic Proteins." Medical News Today. MediLexicon, Intl., 31 Jul. 2008. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/116787.php>

APA
Drug Information Association. (2008, July 31). "DIA/AAPS Co-Sponsored Conference To Examine The Immunogenicity Of Therapeutic Proteins." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/116787.php.

Please note: If no author information is provided, the source is cited instead.


Pharma Industry / Biotech Industry

Most Popular Articles



Follow Our Pharma Industry News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pharma Industry / Biotech Industry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »